BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9436616)

  • 1. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways.
    Hung HC; Lee EH
    Free Radic Biol Med; 1998 Jan; 24(1):76-84. PubMed ID: 9436616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
    Hung HC; Lee EH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
    Sharma A; Kaur P; Kumar V; Gill KD
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice.
    Chen CM; Yin MC; Hsu CC; Liu TC
    Nutrition; 2007; 23(7-8):589-97. PubMed ID: 17574387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.
    Sutphin MS; Buckman TD
    Neurochem Res; 1991 Dec; 16(12):1257-63. PubMed ID: 1784323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.
    Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M
    Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I; Asari S; Nishimoto A; Felten DL
    No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of methamphetamine nigrostriatal toxicity by dietary selenium.
    Kim HC; Jhoo WK; Choi DY; Im DH; Shin EJ; Suh JH; Floyd RA; Bing G
    Brain Res; 1999 Dec; 851(1-2):76-86. PubMed ID: 10642830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY; Jang EH; Park CS; Kang JH
    Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice.
    Mu X; He GR; Yuan X; Li XX; Du GH
    Pharmacol Biochem Behav; 2011 Apr; 98(2):286-91. PubMed ID: 21262257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
    Ren JP; Zhao YW; Sun XJ
    Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
    Thomas B; Saravanan KS; Mohanakumar KP
    Neurochem Int; 2008 May; 52(6):990-1001. PubMed ID: 18164516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G; Jenner P
    Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development.
    Groc L; Bezin L; Foster JA; Jiang H; Jackson TS; Weissmann D; Levine RA
    Neurochem Int; 2001 Aug; 39(2):127-33. PubMed ID: 11408091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
    Kuhlmann AC; Guilarte TR
    Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.